Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin

Microbial Pathogenesis

Volumn 51, Issue 5, 2011, Pages 366-372

  Malekshahi, Ziba V ^a   Gargari, Seyed Latif Mousavi ^a   Rasooli, Iraj ^a   Ebrahimizadeh, Walead ^a  

^a SHAHED UNIVERSITY   (Iran)

Author keywords

Gastritis; Helicobacter pylori; IgY; Treatment

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN Y; PHOSPHATE BUFFERED SALINE; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; UREC IMMUNOGLOBULIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG PURIFICATION; EGG YOLK; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; INFECTION RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCOSA; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; CHICKENS; DISEASE MODELS, ANIMAL; EGG YOLK; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULINS; MICE; MICE, INBRED C57BL;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; MUS;

EID: 80052474150     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.06.002     Document Type: Article

References (38)

1. Konturek J.W. Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. Journal of Physiology and Pharmacology 2003, 54:23-41.
2. Shin J.H., Yang M., Nam S.W., Kim J.T., Myung N.H., Bang W.G., et al. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clinical and Diagnostic Laboratory Immunology 2002, 9:1061-1066.
3. McNamara D., El-Omar E. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Digestive and Liver Disease 2008, 40:504-509.
4. Gao L., Michel A., Weck M.N., Arndt V., Pawlita M., Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Research 2009, 69:6164-6170.
5. Graham D.Y., Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nature Clinical Practice Gastroenterology and Hepatology 2008, 5:321-331.
6. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 2007, 56:772-781.
7. Gisbert J.P., Gisbert J.L., Marcos S., Jimenez-Alonso I., Moreno-Otero R., Pajares J.M. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Alimentary Pharmacology and Therapeutics 2008, 27:346-354.
8. DeLoney C.R., Schiller N.L. Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrobial Agents and Chemotherapy 2000, 44:3368-3373.
9. Trust T.J., Alm R.A., Pappo J. Helicobacter pylori: today's treatment, and possible future treatment. European Journal of Surgery, Supplement 2001, 167:82-88.
10. Marnila P., Rokka S., Rehnberg-Laiho L., Kärkkäinen P., Kosunen T.U., Rautelin H., et al. Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 2003, 8:192-201.
11. Casswall T.H., Nilsson H.O., Björck L., Sjöstedt S., Xu L., Nord C.E., et al. Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scandinavian Journal of Gastroenterology 2002, 37:1380-1385.
12. Carlander D., Kollberg H., Wejåker P.E., Larsson A. Peroral immunotheraphy with yolk antibodies for the prevention and treatment of enteric infections. Immunologic Research 2000, 21:1-6.
13. Sarker S.A., Casswall T.H., Juneja L.R., Hoq E., Hossain I., Fuchs G.J., et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. Journal of Pediatric Gastroenterology and Nutrition 2001, 32:19-25.
14. Fan J., Zuo Y., Li T., Zhang X. Preparation and physicochemical property of chicken yolk immunoglobulin (IgY) against porcine Transmissible Gastroenteritis Virus (TGEV). Frontiers of Agriculture in China 2009, 3:466-470.
15. Sarker S.A., Pant N., Juneja L.R., Hammarström L. Successful treatment of rotavirus-induced diarrhoea in suckling mice with egg yolk immunoglobulin. Journal of Health, Population and Nutrition 2007, 25:465-468.
16. Wu C.J., Wang H., Chan Y.L., Li T.L. Passive immune-protection of small abalone against Vibrio alginolyticus infection by anti-Vibrio IgY-encapsulated feed. Fish and Shellfish Immunology 2011.
17. Hennig-Pauka I., Stelljes I., Waldmann K.H. Studies on the effect of specific egg antibodies against Escherichia coli infections in piglets. Deutsche Tierarztliche Wochenschrift 2003, 110:49-54.
18. Sunwoo H.H., Lee E.N., Gujral N., Suresh M.R. Growth inhibition of Escherichia coli 987P by neutralizing IgY antibodies. Open Immunology Journal 2010, 3:1-8.
19. Sauker S.A. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. Journal of Pediatric Gastroenterology and Nutrition 2001, 32:19-25.
20. Gurtler M., Methner U., Kobilke H., Fehlhaber K. Effect of orally administered egg yolk antibodies on Salmonella enteritidis contamination of hen's eggs. Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health 2004, 51:129-134.
21. Chen W.J., Jiang W., Yao W.M., Guo L.J., Zhang M., Guo F.Y., et al. Effect of boiling chick eggs on activity of IgY against bacillary dysentery and rotavirus. Chinese Journal of Biologicals 2010, 23:1102-1104.
22. Shin J.H. Identification of immunodominant Helicobacter pylori proteins with reactivity to H. pylori-specific egg-yolk immunoglobulin. Journal of Medical Microbiology 2003, 52:217-222.
23. Shin J.H., Nam S.W., Kim J.T., Yoon J.B., Bang W.G., Roe I.H. Identification of immunodominant Helicobacter pylori protoiens with reactivity to H. pylori-specific egg-yolk immunoglobulin. Journal of Medical Microbiology 2003, 52:217-222.
24. Yan J.M.Y., Shao Z.X. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. World Journal of Gastroenterology 2005, 11:421-425.
25. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007, 12:89-102.
26. Nomura S., Suzuki H., Masaoka T., Kurabayashi K., Ishii H., Kitajima M., et al. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils. Helicobacter 2005, 10:43-52.
27. Schade R., Calzado E.G., Sarmiento R., Chacana P.A., Porankiewicz-Asplund J., Terzolo H.R. Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. ATLA Alternatives to Laboratory Animals 2005, 33:129-154.
28. Attallah A.M., Abbas A.T., Ismail H., Abdel-Raouf M., El-Dosoky I. Efficacy of passive immunization with IgY antibodies to a 58-kDa H. pylori antigen on severe gastritis in BALB/c mouse model. Journal of Immunoassay and Immunochemistry 2009, 30:359-377.
29. Koesling J., Lucas B., Develioglou L., Aebischer T., Meyer T.F. Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 2001, 20:413-420.
30. Qiu Y., Wang Y.C., Tao H.X., Zhan D.W., Yuan S.L., Wang P., et al. Identification of B-cell epitopes in urease B subunit of Helicobacter pylori bound by neutralizing antibodies. Vaccine 2010, 28:5220-5227.
31. Tanahashi T., Kita M., Kodama T., Yamaoka Y., Sawai N., Ohno T., et al. Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infection and Immunity 2000, 68:664-671.
32. Tang R.X., Luo D.J., Sun A.H., Yan J. Diversity of Helicobacter pylori isolates in expression of antigens and induction of antibodies. World Journal of Gastroenterology 2008, 14:4816-4822.
33. Cellini L., Marzio L., Ferrero G., Del Vino A., Di Campli E., Grossi L., et al. Transmission of Helicobacter pylori in an animal model. Digestive Diseases and Sciences 2001, 46:62-68.
34. O'Rourke J.L., Lee A. Animal models of Helicobacter pylori infection and disease. Microbes and Infection 2003, 5:741-748.
35. Thompson L.J., Danon S.J., Wilson J.E., O'Rourke J.L., Salama N.R., Falkow S., et al. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infection and Immunity 2004, 72:4668-4679.
36. Jones N.L., Day A.S., Jennings H., Shannon P.T., Galindo-Mata E., Sherman P.M. Enhanced disease severity in Helicobacter pylori-infected mice deficient in fas signaling. Infection and Immunity 2002, 70:2591-2597.
37. Garhart C.A., Redline R.W., Nedrud J.G., Czinn S.J. Clearance of Helicobacter pylori infection and resolution of post immunization gastritis in a kinetic study of prophylactically immunized mice. Infection and Immunity 2002, 70:3529-3538.
38. Shin Ji-Hyun, Roe Im-Hwan, Kim Hyung-Gun Production of anti-Helicobacter pylori ureasespecific immunoglobulin in egg yolk using an antigenic epitope of H. pylori urease. Journal of Medical Microbiology 2004, 53:31-34.